Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients

Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients

Diminished immune response after vaccination occurs in cancer patients. This observational study evaluated the immune response and safety profile after COVID-19 vaccination in radiotherapy patients. The study comprised 53 cancer patients undergoing radiotherapy and voluntarily received the COVID-19...

Full description

Bibliographic Details
Main Authors: Anussara Prayongrat, Patjaya Noppaving, Thitiporn Chobarporn, Natthinee Sudhinaraset, Nattaya Teeyapun, Nussara Pakvisal, Watsamon Jantarabenjakul, Jiratchaya Sophonphan, Chawalit Lertbutsayanukul, Yong Poovorawan
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
vaccination
radiotherapy
immunogenicity
Online Access:https://www.mdpi.com/2076-393X/11/7/1135

Internet

https://www.mdpi.com/2076-393X/11/7/1135

Similar Items